Chronic myeloid leukemia evolving after idiopathic myelofibrosis.
Bennett
Michael
M
Department of Hematology, HaEmek Medical Center, Afula, Israel. benet_m@clalit.org.il
Chubar
Evgene
E
D000328:Adult; D001772:Blood Cell Count; D002892:Chromosomes, Human, Pair 22; D002899:Chromosomes, Human, Pair 9; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000235:genetics; D007964:Leukocytosis / Q000209:etiology; D008297:Male; D008533:Megakaryocytes / Q000378:metabolism; D055728:Primary Myelofibrosis / Q000150:complications* / Q000378:metabolism; D011799:Quinazolines / Q000627:therapeutic use; D013163:Splenomegaly / Q000209:etiology; D013921:Thrombocytopenia / Q000188:drug therapy / Q000209:etiology; D014178:Translocation, Genetic
D005343:Fibrinolytic Agents; D011799:Quinazolines; D016044:Fusion Proteins, bcr-abl; C021139:anagrelide